老年人透析起始后6个月死亡风险的临床风险预测工具
该研究利用加拿大阿尔伯塔省2003年5月至2012年3月期间2199例65岁及以上起始维持性透析的老年人数据,回顾性构建并内部验证了一个7变量19分风险评分,用于预测透析起始后6个月内全因死亡。375例(17.1%)在6个月内死亡,模型区分度C统计量为0.72,校准尚可。评分<5分对应6个月内死亡比例<25%,评分>12分预测超过半数个体在6个月内死亡。
要点
- 19分风险评分包含年龄≥80岁、肾小球滤过率、心房颤动、淋巴瘤、充血性心力衰竭、近6个月住院和转移性癌症。
- 评分<5分者6个月内死亡比例<25%,评分>12分者超过半数在6个月内死亡。
- 模型区分度C统计量=0.72,校准Hosmer-Lemeshow χ2=10.36,P=0.2。
核心结论
- 利用常规可得临床信息构建并内部验证了7变量工具,用于预测老年人透析起始后早期死亡;经成功外部验证后,该工具可能有助于为肾衰竭老年人的决策提供辅助。
研究设计与样本
- 预测模型研究,使用回顾性行政与临床数据,纳入加拿大阿尔伯塔省2003年5月至2012年3月起始维持性透析(排除急性肾损伤)的2199例65岁及以上老年人。
主要发现
- 375例(17.1%)老年人在6个月内死亡。
- 构建的19分风险评分中,年龄80岁或以上2分,肾小球滤过率10至14.9mL/min/1.73m2为1分或≥15mL/min/1.73m2为3分,心房颤动2分,淋巴瘤5分,充血性心力衰竭2分,既往6个月内住院2分,转移性癌症3分。
- 模型区分度C统计量=0.72,校准Hosmer-Lemeshow χ2=10.36,P=0.2。
- 评分<5分对应6个月内死亡个体比例<25%,评分>12分预测超过半数个体在6个月内死亡。
关键数值与推荐
- 19分风险评分中,年龄80岁或以上2分,肾小球滤过率10至14.9mL/min/1.73m2为1分或≥15mL/min/1.73m2为3分。
- 心房颤动2分,淋巴瘤5分,充血性心力衰竭2分,既往6个月内住院2分,转移性癌症3分。
- 评分<5分对应6个月内死亡比例<25%,评分>12分预测超过半数个体在6个月内死亡。
- 模型区分度C统计量=0.72,校准Hosmer-Lemeshow χ2=10.36,P=0.2。
临床怎么用
- 作者认为,经成功外部验证后,该工具可能作为临床决策工具,辅助肾衰竭老年人的决策。
局限性
- 该工具尚未进行外部验证,因此无法评估其普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Information on an individual's risk for death following dialysis therapy initiation may inform the decision to initiate maintenance dialysis for older adults. We derived and validated a clinical risk prediction tool for all-cause mortality among older adults during the first 6 months of maintenance dialysis treatment. STUDY DESIGN: Prediction model using retrospective administrative and clinical data. SETTING & PARTICIPANTS: We linked administrative and clinical data to define a cohort of 2,199 older adults (age ≥ 65 years) in Alberta, Canada, who initiated maintenance dialysis therapy (excluding acute kidney injury) in May 2003 to March 2012. CANDIDATE PREDICTORS: Demographics, laboratory data, comorbid conditions, and measures of health system use. OUTCOMES: All-cause mortality within 6 months of dialysis therapy initiation. ANALYTICAL APPROACH: Predicted mortality by logistic regression with 10-fold cross-validation. RESULTS: 375 (17.1%) older adults died within 6 months. We developed a 19-point risk score for 6-month mortality that included age 80 years or older (2 points), glomerular filtration rate of 10 to 14.9mL/min/1.73m2 (1 point) or ≥15mL/min/1.73m2 (3 points), atrial fibrillation (2 points), lymphoma (5 points), congestive heart failure (2 points), hospitalization in the prior 6 months (2 points), and metastatic cancer (3 points). Model discrimination (C statistic = 0.72) and calibration (Hosmer-Lemeshow χ2=10.36; P=0.2) were reasonable. As examples, a score < 5 equated to <25% of individuals dying in 6 months, whereas a score > 12 predicted that more than half the individuals would die in the first 6 months. LIMITATIONS: The tool has not been externally validated; thus, generalizability cannot be assessed. CONCLUSIONS: We used readily available clinical information to derive and internally validate a 7-variable tool to predict early mortality among older adults after dialysis therapy initiation. Following successful external validation, the tool may be useful as a clinical decision tool to aid decision making for older adults with kidney failure.
引用
- Wick JP, Turin TC, Faris PD, et al. A Clinical Risk Prediction Tool for 6-Month Mortality After Dialysis Initiation Among Older Adults. Am J Kidney Dis. 2016. PMID: 27856091. doi:10.1053/j.ajkd.2016.08.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。